Stockscreener 앱 받기
3.1699
3.06%
-0.1001
전일 마감가:
$3.27
열려 있는:
$3.26
하루 거래량:
32,088
Relative Volume:
0.29
시가총액:
$40.33M
수익:
-
순이익/손실:
$-70.20M
주가수익비율:
-0.0707
EPS:
-44.82
순현금흐름:
$-50.66M
1주 성능:
-4.81%
1개월 성능:
+16.97%
6개월 성능:
+26.80%
1년 성능:
-80.58%
1일 변동 폭
$3.019
$3.31
1주일 범위
$3.019
$3.50
52주 변동 폭
$1.70
$17.74
Onkure Therapeutics Inc Stock (OKUR) Company Profile
명칭
Onkure Therapeutics Inc
전화
(720) 307-2892
주소
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
OKUR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OKUR
Onkure Therapeutics Inc
|
3.14 | 44.24M | 0 | -70.20M | -50.66M | -44.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.17 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
633.36 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
427.44 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.22 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.71 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Onkure Therapeutics Inc Stock (OKUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-30 | 개시 | Evercore ISI | Outperform |
| 2024-12-05 | 개시 | Leerink Partners | Outperform |
| 2024-10-10 | 개시 | Oppenheimer | Outperform |
| 2023-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-12-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-12-15 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-12-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2023-12-14 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-12-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-11-15 | 개시 | William Blair | Outperform |
| 2023-08-28 | 개시 | H.C. Wainwright | Buy |
| 2023-07-03 | 개시 | BofA Securities | Buy |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2022-01-27 | 개시 | Robert W. Baird | Outperform |
| 2021-12-21 | 개시 | H.C. Wainwright | Buy |
| 2021-11-22 | 개시 | Ladenburg Thalmann | Buy |
| 2021-05-04 | 개시 | Jefferies | Buy |
| 2021-05-04 | 개시 | Piper Sandler | Overweight |
| 2021-05-04 | 개시 | SVB Leerink | Outperform |
모두보기
Onkure Therapeutics Inc 주식(OKUR)의 최신 뉴스
How to read the order book for OnKure Therapeutics Inc.Portfolio Value Summary & Growth Oriented Trade Recommendations - newser.com
Custom watchlist performance reports with OnKure Therapeutics Inc.2025 Year in Review & Long-Term Capital Growth Ideas - newser.com
Will OnKure Therapeutics Inc. stock remain a Wall Street favoriteWeekly Market Outlook & Accurate Entry/Exit Alerts - newser.com
Institutional scanner results for OnKure Therapeutics Inc.2025 Risk Factors & Daily Profit Maximizing Tips - newser.com
How OnKure Therapeutics Inc. stock reacts to inflationary pressuresProfit Target & Risk Managed Investment Strategies - newser.com
Onkure Therapeutics Inc expected to post a loss of $1.20 a shareEarnings Preview - TradingView
Is it time to cut losses on OnKure Therapeutics Inc.Portfolio Update Summary & Daily Stock Trend Watchlist - newser.com
OnKure Therapeutics Inc.’s volatility index tracking explainedGold Moves & Short-Term Trading Alerts - newser.com
What valuation multiples suggest for OnKure Therapeutics Inc. stockWeekly Market Outlook & Expert Curated Trade Setups - newser.com
Will OnKure Therapeutics Inc. stock continue upward momentumWeekly Loss Report & Free Growth Oriented Trading Recommendations - newser.com
What momentum shifts mean for OnKure Therapeutics Inc.Earnings Recap Summary & Growth-Oriented Investment Plans - newser.com
Analyzing drawdowns of OnKure Therapeutics Inc. with statistical toolsIPO Watch & Target Return Focused Stock Picks - newser.com
Is OnKure Therapeutics Inc. stock ready for a breakoutJuly 2025 Analyst Calls & Expert Approved Momentum Ideas - newser.com
OnKure Therapeutics, Inc. (NASDAQ:OKUR) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
How rising interest rates impact OnKure Therapeutics Inc. stockJuly 2025 Short Interest & Risk Controlled Daily Plans - newser.com
Can you recover from losses in OnKure Therapeutics Inc.2025 Pullback Review & Risk Controlled Daily Plans - newser.com
How OnKure Therapeutics Inc. stock compares to market leadersWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
Is OnKure Therapeutics Inc. stock affected by interest rate hikesExit Point & Safe Entry Zone Identification - fcp.pa.gov.br
Will OnKure Therapeutics Inc. stock continue dividend increases2025 Growth vs Value & Detailed Earnings Play Strategies - fcp.pa.gov.br
Can OnKure Therapeutics Inc. stock maintain growth trajectory2025 Dividend Review & Daily Oversold Bounce Ideas - fcp.pa.gov.br
How strong is OnKure Therapeutics Inc. stock revenue growth2025 Earnings Impact & Proven Capital Preservation Tips - fcp.pa.gov.br
Why hedge funds are buying OnKure Therapeutics Inc. stockJuly 2025 Price Swings & Comprehensive Market Scan Reports - fcp.pa.gov.br
What Analyst Models Predict for Ravinder Heights Limiteds 5Year GrowthValue Traps to Avoid & Big Gains Low Budget - earlytimes.in
Onkure Therapeutics Inc (OKUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.49%
0.29%
자본화:
|
볼륨(24시간):